Table E1.
Survey questions and response options
| Q1. Does your Pediatric Asthma clinic continue to run physically? |
| Yes |
| No |
| Q2. Has the number of evaluated cases changed in the last month? |
| Increased |
| Stable |
| Decreased |
| Q3. Has the planned monitoring frequency of patients changed? |
| No |
| More frequently |
| Less frequently |
| Currently unstable/unknown |
| Q4. Do you offer a virtual (online or telephone) clinic/consultation? |
| Yes |
| No |
| Q5. In the last few weeks, has the number of evaluated cases |
| Increased? |
| Remain stable? |
| Decreased? |
| Q6. Approximately how many patients do you see per week (number)? |
| Number: _______ |
| Q7. Has the type/severity/priority of patients changed? |
| No |
| Yes—more severe |
| Yes—patients receiving biologicals only |
| Yes—other priority please specify |
| Q8. Which of the following methods do you use to monitor your patients? |
| A standardized questionnaire |
| An asthma control test (ACT, ACQ, other) |
| Peak flow meter reading |
| Portable spirometer reading |
| Adherence evaluation |
| Diary cards |
| Symptom-recording app/telemedicine platform |
| Other (please specify) |
| Q9. What has been your experience with your virtual clinic so far? |
| As good as the face-to-face clinic |
| Somehow compromised but still okay |
| Only viable for a short period of time |
| Unsatisfactory—low-quality medical service |
| Other (please specify): _______ |
| Q10. Do you offer a helpline for your pediatric asthma patients? |
| Yes |
| No |
| Q11. If you do not offer physical or virtual clinic, please describe expectations/plans around pediatric asthma patients in the near future. |
| Free text: __________ |
| Q12. Do you actively send advice to your asthma patients? |
| No |
| By email |
| Through social media |
| Through website |
| Q13. In the last few weeks have you received any new patients? |
| No |
| Yes—a few |
| Yes—several |
| Q14. If yes, how many new patients do you receive every week, during the COVID-19 pandemic? |
| Number: _____ |
| Q15. In your asthma clinic, do you have any patients receiving biologicals? |
| Yes |
| No |
| Q16. If yes, how many? |
| Number: _____ |
| Q17. Do they continue their regular dosage? |
| Yes |
| No—stopped |
| No—reduced frequency |
| Q18. Has any of your pediatric asthma patients had confirmed COVID? |
| No |
| Yes |
| Q19. If yes, approximately how many? |
| Number: _____ |
| Q20. Their symptoms at presentation included: |
| Runny/blocked nose. Percentage: _____ |
| Cough. Percentage: _____ |
| Wheeze. Percentage: _____ |
| Shortness of breath. Percentage: _____ |
| Fever. Percentage: _____ |
| Nonrespiratory symptoms/other. Percentage: _____ |
| Q21. Their clinical course in regard to their asthma has been: |
| Mild. Percentage: _____ |
| Moderate (treated at home). Percentage: _____ |
| Severe exacerbation (emergency visit or hospital admission). Percentage: _____ |
| Required ICU admission or intubation. Percentage: _____ |
| Death. Percentage: _____ |
| Q22. Has any of your pediatric asthma patients had suspected, but not confirmed COVID? |
| No |
| Yes |
| Q23. If yes, approximately how many? |
| Number: _____ |
| Q24. Their symptoms at presentation included: |
| Runny/blocked nose. Percentage: _____ |
| Cough. Percentage: _____ |
| Wheeze. Percentage: _____ |
| Shortness of breath. Percentage: _____ |
| Fever. Percentage: _____ |
| Nonrespiratory symptoms/other. Percentage: _____ |
| Q25. Their clinical course in regard to their asthma has been: |
| Mild. Percentage: _____ |
| Moderate (treated at home). Percentage: _____ |
| Severe exacerbation (emergency visit or hospital admission). Percentage: _____ |
| Required ICU admission or intubation. Percentage: _____ |
| Death. Percentage: _____ |
| Q26. In the last month, approximately how many patients have you monitored (either physically or virtually)? |
| Number: _____ |
| Q27. From the patients you have monitored, what is the proportion with |
| Well-controlled asthma. Percentage: _____ |
| Partially controlled asthma. Percentage: _____ |
| Uncontrolled asthma. Percentage: _____ |
| Q28. How does this compare with your expectations for the same patients? |
| As expected. Percentage: _____ |
| Better that expected. Percentage: _____ |
| Worse than expected. Percentage: _____ |
| Q29. What was the proportion of patients with regard to treatment changes? |
| Increased treatment. Percentage: _____ |
| Continued treatment. Percentage: _____ |
| Decreased treatment. Percentage: _____ |
| Q30. Is availability or access to medication an issue? |
| Yes |
| No |
| Q31. Have you observed changes in adherence to controller medications? |
| No changes in adherence. Percentage: _____ |
| Increased adherence. Percentage: _____ |
| Reduced adherence. Percentage: _____ |
| Any comment on adherence changes? _____ |
| Q32. Number of your patients (approximately) who have suffered an exacerbation during the last month and treated at outpatients (independent of COVID)? |
| Number: _____ |
| Q33. Number of your patients (approximately) who have suffered an exacerbation during the last month and were hospitalized (independent of COVID)? |
| Number: _____ |
| Q34. In which country do you practice? |
| Q35. In what setting do you practice? |
| Tertiary/university hospital |
| Secondary hospital |
| Primary care |
| Community center |
| Q36. Your email (optional) |
| Q37. Your name (optional) |
ACQ, Asthma Control Questionnaire; ACT, Asthma Control Test; ICU, intensive care unit.